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A NOVEL APPROACH TO MASS TORT CLASS ACTIONS: THE
BILLION DOLLAR SETTLEMENT IN THE SULZER ARTIFICIAL
HIP AND KNEE LITIGATION: A SYMPOSIUM
PROFESSOR LANDEVER: Welcome. My name is Professor Arthur
Landever and along with Professor Susan Becker I would like to welcome you to this
symposium. I know you'll find it worthwhile. I would like to call on Dean
Steinglass for some introductory remarks.
DEAN STEINGLASS: Hold the applause until I'm done.
Let me just welcome everyone here. I know many of the people in the room are
students, and we always welcome you here. And I'm also very pleased to see so
many people wearing coats and ties and business suits, so I assume this program has
reached out to the legal community as well, and that's as it should be. This law
school really is very much a part of this legal community.
And when we do events like this, we are delighted at people who take a short
walk or bus and come visit us. They can't come by car, of course, because parking is
always at a premium, but we do welcome you here.
My only role is to talk while the tech guys get things set up, but I do want to
welcome everyone here. As I say, as a recovering civil procedure teacher, I'm quite
interested in finding out what is going to be said.
I do want to extend a very special thanks to Judge O'Malley and Eric Kennedy,
to Sidney Backstrom appearing in person in case Mr. Scruggs says something wrong
or doesn't come in on the screen, Judge McMonagle, and my colleague and former
student, Susan Becker. All the good things she does, she did on her own. The bad
things are things she learned in civil procedure from me. And she's done a great job.
Of course, I want to thank you, Arthur Landever, for putting this together.
Have a good conference.
MS. BECKER: It is indeed an honor to be here today with Judge O'Malley and
this esteemed panel of attorneys to discuss class actions.
As you know our primary focus today is on the Sulzer knee and hip replacement
class action. My remarks are intended to place this fascinating and innovative case
in the larger context of the many issues that we all face as participants in our modem
civil justice system.
I am going to do this by briefly refreshing your recollection as to the procedural
requirements for modern class actions, describing the ongoing controversy
surrounding use of these procedures, and touching on reform efforts currently
underway. I will then provide a short introduction to the Sulzer litigation and
introduce each panelist.
1. Class Action Requirements
Modern class action involve a few plaintiffs - known as the "representative
parties" stepping forward and filing suit on behalf of others who are similarly
situated - that is, other persons who have allegedly be harmed through the action of a
particular defendant or defendants.
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In federal courts, and many state courts as well, the prerequisites for pursing a
case as a class action are spelled out in Rule 23.' This rule is intended to be
transsubstantive, meaning that it applies regardless of whether the plaintiffs' claims
are based in tort, contract, civil rights, or other theory of recovery.
Rule 23(a) lists four requirements, all of which must be met, with the burden on
the parties seeking class certification. These are:
* numerosity - the class is so large that individual joinder of all members
is not practicable;
• common questions - existence of questions of law OR fact common to
everyone in the class;
" typicality - a showing that the claims or defenses of a representative
parties are typical of the class; and
* adequacy - a showing that the representative parties will adequately
represent the class interests.
In addition to satisfying all of those elements, the proposed class action has to
meet at least one of the three criteria, or types, of class actions spelled out in 23(b) -
the most common being a 23(b)(3) class action. It provides that a "class action is
appropriate if the court finds there are questions of law or fact common to the class
that predominate over individual member's unique situations, and that a class action
is a superior means to achieve a fair and efficient adjudication of the controversy."
Rule 23 also allows a judge to certify subclasses based on specific issues of law
or fact, and Judge O'Malley did exactly, that in the Sulzer case. Judge O'Malley's
Memorandum and Order in the Sulzer case that explains how this case meets all the
Rule 23(a) and 23(b)(3) criteria is included in the CLE packet handed out today.'
Rule 23 has a number of additional requirements that place specific
responsibilities on the judge, the parties, and their respective counsel to make sure
that the decision on class certification is made expediently and that proper notice is
provided to class members who will later be bound by the decision. And, of course,
one of the most important requirements is class actions cannot, according to the
rules, be dismissed or compromised without the court's approval.
2. Controversy Surrounding Class Actions
The intent of the class action device is to provide fair and efficient remedies to
large number of persons harmed though the wrongful act of a defendant. Class
actions increasingly have come under fire f6r not meeting these intended objectives.
Critics argue that the process has become increasingly complex and burdensome
for would-be class members. Some also claim that class actions have evolved into a
procedure that optimizes revenues for plaintiffs' and defense lawyers, limits liability
and accountability of defendants, and entices judges to certify questionable class
actions as a means of managing otherwise unwieldy dockets.
In short, critics contend, modern class actions all too frequently benefit everyone
in the litigation process except the class members whom class actions were designed
to protect. They frequently support their criticism by citing class actions that result
'FED. R. Civ. P. 23.
2See Appendix 4.
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in a "fistful of coupons" for class members and substantial cash awards to the
attorneys.
Defenders of modern class actions counter that this device has been used fairly
and efficiently in a wide variety of cases, and has proven especially helpful to people
who would otherwise lack the resources to pursue individual lawsuits. Proponents
claim that class actions help level the playing field in the classic David and Goliath
battles common to modern litigation.
In addition to benefiting individual claimants, proponents argue, class actions
serve the common good by alerting putative class members and the public to
injustices and injuries of which they might not have been aware and by developing
creative, comprehensive settlements that preserve continued economic viability of
defendants.
These ongoing debates over class actions have filled volumes of legal periodicals
and resulted in significant reform activities at the state and federal levels. And keep
in mind that proposals to change class action practices are part of much larger efforts
to reform many aspects of our civil justice system - not just as to procedure but in
terms of tort law reforms as well.
As to class actions specifically, Federal Rule Civil Procedure 23 and its state
counterparts have been intensely scrutinized over the past decade, but until recently,
changes in the actual text of these rules governing class actions have been relatively
minimal. Congress has enacted extensive legislation in 1995 and 1997 reforming
class actions based on claims of federal securities law violations, but to date, has
resisted additional efforts to "federalize" class actions in other controversial areas
such as mass tort and products liability. It now appears that extensive changes to
class action procedures are just around the corner.
3. Proposed Reforms
In March of this year the U.S. Supreme Court approved substantial changes to
Rule 23 and, pursuant to standard federal rule making procedures, forwarded them
on to Congress. These changes are explained in detail in the CLE program materials
and I won't belabor them here. But it is clear from even a cursory reading that these
amendments are intended to address the recurring criticisms of class action practice
by requiring heightened judicial scrutiny of proposed class actions and additional
safeguards for ensuring the fairness of the settlement to all class members.
The changes have been forwarded to Congress for its approval. The way the
process works is that if Congress does NOT take action on such recommendations,
and they changes become law on December 1 of this year.
However, Congress has the power to reject or modify the provisions. And that is
a possibility in this case. Legislation is pending in both the House and the Senate
that would substantially change class action practice.
The Class Action Fairness Act of 2003 (H.R. 1115) for example would greatly
extend federal court jurisdiction over class actions that previously could only have
been litigated in state courts.' The legislation would also require requirement "plain
English" notices to class members and increased scrutiny by courts regarding
settlements, especially those involving "coupons" or other non-cash awards to class
members.
3H.R. 1115 10 8 h Cong. (2003).
2001-021
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So it is unclear at this juncture what type of class action reforms will emerge
from Congress - or what its actual impact will be on class action practice.
4. The Sulzer Litigation
Even if these proposed reforms come to fruition, debate over class actions will no
doubt continue for many years. Obviously we cannot resolve all these issues in the
context of this two-hour symposium. Today we reflect upon some of these recurring
issues - not just related to class actions but also in the area of mass tort claims-in the
context of the somewhat unique approach taken in the Sulzer Hip Prosthesis and
Knee Prosthesis Liability Litigation, which as you know, culminated in a $1 billion
dollar settlement last spring in the U.S. District Court for the N.D. Ohio.
I emphasize here that we are focusing upon the Sulzer case NOT because it
demonstrates the need for reforms; rather, it appears to us unique and creative
approach to resolving a mass tort class action.
Defendants are Sulzer AG, a Switzerland based precision manufacturing
conglomerate; Sulzer Medica AG, and Sulzer's U.S. subsidiary, Sulzer Orthopedics
Inc., based in Austin, Texas. Plaintiffs are individuals who received either an
artificial hip or knee joint manufactured by Sulzer. Patients who received these
implants experienced serious difficulties with them, necessitating some to have
replacement surgery. By August 2001, for example, more than 2,400 people had
undergone operations to replace the defective hip or knee implants and it appeared
that perhaps as many as 4,000 total replacements surgeries would ultimately be
performed.
Also in August 2001, a $15 million judgment was entered against Sulzer on
behalf of three Corpus Christi women who prevailed in a Texas state court. Sulzer
aggressively sought class action treatment of the claims stemming from its defective
joints. In a novel move, Sulzer agreed to open its books to an independent review
firm to determine how much the firm could pay without going bankrupt. The
number was $1 billion.
As negotiated by the parties and approved by the court, the final settlement
provides compensation for each member of the class based on a variety of factors,
such as whether the member has undergone - or is likely to undergo - a revision to
replace the defective part. The details of the settlement are included in the "Class
Member and Attorney Guide" included at the end of your CLE program materials.' I
will end my remarks here for fear of stealing the thunder of any of our panelists.
5. Introduction of Panelists
Each of our panelists possesses an outstanding resume. In the interest of time, I
am only going to introduce them briefly in the order in which they will speak.
R. Eric Kennedy served as lead plaintiffs' counsel in the Sulzer case. Mr.
Kennedy is the managing partner of Weisman, Goldberg & Weisman, L.P.A. and his
areas of expertise include medical malpractice, product liability, and class actions.
He sat on the National Settlement Committee of the Breast Implant litigation and
served as class counsel in the $4.8 billion diet drug settlement.
4See Appendix 3.
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